EKF Diagnostics will be exhibiting at the Diabetes Kongress 2026, taking place from 13-16 May 2026 at CityCube Berlin, Germany.
EKF delivers diagnostic technologies and biotechnology solutions, empowering healthcare professionals and laboratory teams to make informed clinical decisions through point-of-care testing and life sciences applications.
Meet with EKF at the event, where our team will be showcasing our specialised range of point-of-care medical diagnostic solutions, including:
Diabetes Care: Featuring the Biosen C-Line, Quo-Lab® and Quo-Test® HbA1c analyzers, providing accurate and efficient glucose, HbA1c, lactate and B-HB measurments to support diabetes diagnosis and monitoring.
The Diabetes Kongress 2026 brings together leading clinicians, researchers, and healthcare professionals to share the latest advancements in diabetes care, research, and technology, fostering collaboration and innovation within the field.
Don’t hesitate to contact your EKF Sales representative or email info@ekfdiagnostics.com to arrange a dedicated meeting during the event.
EKF continues to lead the way with innovative point-of-care diagnostic solutions, enabling rapid, accurate, and accessible testing. Our technologies support informed decision-making, timely interventions, and improved patient outcomes across a wide range of healthcare settings.
We look forward to connecting with you in Berlin and discussing how EKF diagnostic solutions can support your diabetes care and clinical testing needs.